Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Foresite Capital
Deal Size : $110.0 million
Deal Type : Series A Financing
RayThera Raises $110 Million in Series A Financing
Details : The proceeds from the financing will be used to advance RayThera’s lead drug candidates through Phase 1 clinical studies.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 04, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Foresite Capital
Deal Size : $110.0 million
Deal Type : Series A Financing